We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
-0.88%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$1.61T
AUM Growth
-$12.9B
Cap. Flow
+$55.8B
Cap. Flow %
3.47%
Top 10 Hldgs %
31.25%
Holding
4,629
New
160
Increased
3,465
Reduced
677
Closed
115

Sector Composition

1 Technology 31.41%
2 Financials 12.78%
3 Consumer Discretionary 9.97%
4 Healthcare 9.79%
5 Communication Services 9.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSHD icon
1851
Goosehead Insurance
GSHD
$1.22B
$26M ﹤0.01%
608,872
-107,276
-15% -$6M
WVE icon
1852
Wave Life Sciences
WVE
$1.14B
$26M ﹤0.01%
3,579,099
+408,989
+13% +$5.33M
XXI
1853
Twenty One Capital Inc
XXI
$1.87B
$25.9M ﹤0.01%
+4,051,834
New +$29.7M
REAL icon
1854
The RealReal
REAL
$1.36B
$25.9M ﹤0.01%
2,852,047
+404,865
+17% +$5.12M
ALNT icon
1855
Allient
ALNT
$1.51B
$25.9M ﹤0.01%
438,184
+69,698
+19% +$4.39M
PCRX icon
1856
Pacira BioSciences
PCRX
$997M
$25.9M ﹤0.01%
1,143,820
-25,771
-2% -$573K
OSBC icon
1857
Old Second Bancorp
OSBC
$1.19B
$25.9M ﹤0.01%
1,282,011
-83,437
-6% -$1.67M
CRAI icon
1858
CRA International
CRAI
$1.09B
$25.8M ﹤0.01%
159,603
+4,708
+3% +$849K
DEC
1859
Diversified Energy Company
DEC
$917M
$25.8M ﹤0.01%
1,480,206
+727,836
+97% +$10.3M
CSR
1860
Centerspace
CSR
$927M
$25.8M ﹤0.01%
449,258
+12,062
+3% +$758K
PMT
1861
PennyMac Mortgage Investment
PMT
$857M
$25.8M ﹤0.01%
2,213,348
+100,163
+5% +$1.24M
MBC icon
1862
MasterBrand
MBC
$1.14B
$25.8M ﹤0.01%
3,098,501
+88,073
+3% +$952K
PNTG icon
1863
Pennant Group
PNTG
$1.39B
$25.7M ﹤0.01%
842,138
+22,090
+3% +$683K
PVLA
1864
Palvella Therapeutics
PVLA
$2.18B
$25.6M ﹤0.01%
205,609
+26,617
+15% +$2.78M
EYPT icon
1865
EyePoint Inc
EYPT
$1.16B
$25.6M ﹤0.01%
1,983,665
+84,298
+4% +$1.26M
ASTH icon
1866
Astrana Health
ASTH
$2.33B
$25.5M ﹤0.01%
1,038,085
+9,917
+1% +$235K
OCFC icon
1867
OceanFirst Financial
OCFC
$1.7B
$25.4M ﹤0.01%
1,410,048
-10,394
-0.7% -$191K
WS icon
1868
Worthington Steel
WS
$1.74B
$25.4M ﹤0.01%
837,890
+62,694
+8% +$2.43M
MEOH icon
1869
Methanex
MEOH
$4.21B
$25.4M ﹤0.01%
337,302
-19,080
-5% -$960K
GLUE icon
1870
Monte Rosa Therapeutics
GLUE
$1.98B
$25.4M ﹤0.01%
1,540,812
+335,968
+28% +$6.42M
ENVX icon
1871
Enovix
ENVX
$1.11B
$25.2M ﹤0.01%
4,872,090
+458,598
+10% +$2.87M
TYRA icon
1872
Tyra Biosciences
TYRA
$1.93B
$25.2M ﹤0.01%
658,482
+726
+0.1% +$23.5K
NUVB icon
1873
Nuvation Bio
NUVB
$2.05B
$25.2M ﹤0.01%
5,863,654
+151,358
+3% +$843K
HLIT icon
1874
Harmonic Inc
HLIT
$1.41B
$25.1M ﹤0.01%
2,794,248
+58,599
+2% +$582K
CRVS icon
1875
Corvus Pharmaceuticals
CRVS
$1.25B
$25.1M ﹤0.01%
1,712,741
+239,715
+16% +$3.83M

Similar funds